Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1661867rdf:typepubmed:Citationlld:pubmed
pubmed-article:1661867lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1661867lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:1661867lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:1661867lifeskim:mentionsumls-concept:C1548161lld:lifeskim
pubmed-article:1661867pubmed:issue17lld:pubmed
pubmed-article:1661867pubmed:dateCreated1992-2-3lld:pubmed
pubmed-article:1661867pubmed:abstractTextThe Authors report their personal experience of surgical treatment following neo-adjuvant therapy in NSCLC (III a N2) in order to assess: 1) the feasibility and safety of surgical treatment following major responses to neoadjuvant chemotherapy; 2) the sectile rate; and 3) the survival rate. Preliminary results show that: 1) chemotherapy using cisplatin and VP-16 gives a high rate of major responses in these patients; 2) surgery is feasible; 3) there is high radical sectile rate; 4) further research is needed to obtain statistical significance.lld:pubmed
pubmed-article:1661867pubmed:languageitalld:pubmed
pubmed-article:1661867pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1661867pubmed:citationSubsetIMlld:pubmed
pubmed-article:1661867pubmed:statusMEDLINElld:pubmed
pubmed-article:1661867pubmed:monthSeplld:pubmed
pubmed-article:1661867pubmed:issn0026-4733lld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:DarwishSSlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:TonatoMMlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:CavalieriEElld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:MercatiUUlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:MaranzanoEElld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:CheccagliniFFlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:CrinòLLlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:FiaschiniPPlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:MinottiVVlld:pubmed
pubmed-article:1661867pubmed:authorpubmed-author:MeacciMMlld:pubmed
pubmed-article:1661867pubmed:issnTypePrintlld:pubmed
pubmed-article:1661867pubmed:day15lld:pubmed
pubmed-article:1661867pubmed:volume46lld:pubmed
pubmed-article:1661867pubmed:ownerNLMlld:pubmed
pubmed-article:1661867pubmed:authorsCompleteNlld:pubmed
pubmed-article:1661867pubmed:pagination879-84lld:pubmed
pubmed-article:1661867pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:meshHeadingpubmed-meshheading:1661867-...lld:pubmed
pubmed-article:1661867pubmed:year1991lld:pubmed
pubmed-article:1661867pubmed:articleTitle[Surgery after neo-adjuvant therapy of non-small cell lung cancer. Preliminary results].lld:pubmed
pubmed-article:1661867pubmed:affiliationUnità di Chirurgia, Ospedale R. Silvestrini, Perugia.lld:pubmed
pubmed-article:1661867pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1661867pubmed:publicationTypeEnglish Abstractlld:pubmed